Kontakt | Impressum | Spendenkonto | English
Startseite Aktuelles Die Klinik Informationen für Patienten » Forschung Lehre & Ausbildung Mitarbeiter

Publikationen 2005

2007 | 2006 | 2005 | 2004 | 2003

 

AG NeuroOnkologie

  1. Koch HJ, Roeber S, Zimmermann U, Schäfer C, Villarubia V,  Bogdahn U, Steinbrecher A: „Spinale und zerebrale Meningeosis eines sekundär malignisierten Melanozytoms des Kleinhirnbrückenwinkles“. Wien Med Wochenschr 155, 360-364 (2005).
  2. Koch HJ, Steinbrecher A, Circannual periodicity of births in patients with optic neuritis. Chronobiol Int 22, 945-948
  3. Koch H, Horn M, Bogdahn U, Ickenstein GW, The relationship between plasma D-Dimer concentrations in patients and acute ischemic stroke subtypes, J Stroke & Cerebrovas Dis 2005, 10 (5): 1-6 
  4. Hau P, Kunz-Schughart LA, Rummele P, Arslan F, Dorfelt A, Koch H, Lohmeier A, Hirschmann B, Muller A, Bogdahn U, Bosserhoff AK. Tenascin-C protein is induced by Transforming Growth Factor-ss1 but does not correlate with time to tumor progression in high-grade gliomas. J Neurooncol. 2005 Nov 15;:1-7
  5. Schlingensiepen R, Goldbrunner M, Szyrach MNJ, Stauder G, Jachimczak P, Bogdahn U, Schulmeyer F, Hau P, Schlingensiepen KH. Intracerebral and Intrathecal Infusion of the TGF-ß2 Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety. Oligonucleotides, 15(2):94-104
  6. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005, 252 (3):291-299. Epub 2005 Feb 23.
  7. Koch HJ, Hau P. ROC Analysis as an Additional Method to Characterize Time to Event Data. Pathol Oncol Res. 2005;11(1):50-2.
  8. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96.
  9. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 Mar 10;352(10):997-1003.
  10. Jachimczak P, Apfel R, Bosserhoff, A-K., Fabel K, Hau P, Tschertner I, Wise P, Schlingensiepen KH, Schuler-Thurner B, Bogdahn U. Inhibition of immunosuppressive effects of Melanoma Inhibiting Activity (MIA) by antisense techniques. Int J Cancer. 2005 Jan 1;113(1):88-92.
  11. „Idiopathische, hypertrophische, kraniale Pachymeningitis“ Beier, D., Wilhelm, H. Klinische Monatsblätter für Augenheilkunde 09/2005: 740-745
  12. "FasL (CD95L/APO-1L) Resistance of Neurons Mediated by Phosphatidylinositol 3-Kinase–Akt/Protein Kinase B Dependent Expression of Lifeguard/Neuronal Membrane Protein 35" (2005) C.P. Beier, J. Wischhusen, M. Gleichmann, E. Gerhardt, A. Pekanovic, A. Krueger, V. Taylor, U. Suter, P.H. Krammer, M. Endres, M. Weller, J.B. Schulz; Journal of Neuroscience, 25, 6765-6774.

 

AG Schlaganfall / Tempis

  1. H.J. Audebert, C. Kukla, S. Clarmann v. Claranau, J. Kühn, B. Vatankhah, J. Schenkel, G. Ickenstein, R.L. Haberl, M. Horn (2005) Telemedicine for safe and extended use of thrombolysis in stroke. The telemedic pilot project of an integrated stroke care in South-East Bavaria (TEMPiS). STROKE 36:287-291
  2. W.F. Haupt, J. Rudolf, R. Firsching, H.C. Hansen, T. Henze, M. Horn, W. Müllges (2005) Akutversorgung bewusstloser Patienten in einer interdisziplinären Notaufnahme. INTENSIVMED, 42:457-467
  3. M.S. Dittmar, N.P. Fehm, B. Vatankhah, U, Bogdahn, F. Schlachetzki, M. Horn (2005) Adverse effects of the intraluminal filament model of middle cerebral artery occlusion (letter). STROKE 36:530-532
  4. B. Vatankhah, M.S. Dittmar, N. P. Fehm, P. Erban, G.W. Ickenstein, W. Jakob, U. Bogdahn, M. Horn (2005) Thrombolysis for stroke in the elderly. J THROMB THROMBOLYSIS 20:25-30
  5. Erban P, Woertgen C, Luerding R, Bogdahn U, Schlachetzki F, Horn M.: Long-term outcome after hemicraniectomy for space occupying right hemispheric MCA infarction. Clin Neurol Neurosurg. 2005 Aug 29
  6. Haas S, Jürgens T, Vatankhah B, Schwarz S, Schuierer G, Bogdahn U, Steinbrecher A: Multiple Ischemic Lesions in the Vertebro-Basilar Region in Temporal Arteritis (Multiple Ischämien im vertebro-basilären Stromgebiet bei Arteriitis temporalis. Nervenarzt epub 18.05.05
  7. Fehm NP, Vatankhah B, Dittmar MS, Tevetoglu Y, Retzl G, Horn M. Closing microvascular lesions with fibrin-sealant attached muscle pads. Microsurgery 2005, 25(7): 570-4.
  8. Fehm NP, Vatankhah B, Dittmar MS, Retzl G, Schuierer G, Horn M, Schlachetzki F. Application of clinical scanners in rats: experimental carotid imaging using MRI, spiral CT and color Duplex ultrasound. J Neuroimaging 2005, 15: 319-25.
  9. Vatankhah B, Dittmar MS, Fehm NP, Erban P, Ickenstein GW, Jakob W, Bogdahn U, Horn M. Thrombolysis for stroke in the elderly. J Thromb Thrombolysis 2005, 20(1): 5-10.
  10. Dittmar MS, Vatankhah B, Fehm NP, Retzl G, Schuierer G, Bogdahn U, Schlachetzki F, Horn M. The role of ECA transection in the development of masticatory lesions in the MCAO filament model. Exp Neurol 2005, 195(2): 372-8.
  11. Dittmar MS, Fehm NP, Vatankhah B, Bogdahn U, Schlachetzki F. Adverse effects of the intraluminal filament model of middle cerebral artery occlusion. Stroke 2005, 36(3): 530-2.
  12. HJ Audebert, C Kukla, S Clarmann von Claranau, J Kühn, B Vatankhah, J Schenkel, GW Ickenstein, RL Haberl, M Horn. „Telemedicine for safe and extended use of thrombolysis in stroke – The Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria”.  Stroke. 2005 Feb; 36(2): 287-291.
  13. MS Dittmar, NP Fehm, B Vatankhah, U Bogdahn, F Schlachetzki. Letter to the Editor: “Adverse effects of the intraluminal filament model of middle cerebral artery occlusion”. Stroke. 2005 Mar; 36(3): 530-532.
  14. GW Ickenstein, M Horn, J Schenkel, B Vatankhah, U Bogdahn, R Haberl,  HJ Audebert. „The use of telemedicine in combination with a new Stroke-Code-Box significantly increases t-PA use in rural communities”. Neurocritical Care. 2005; 3(1): 27-32.
  15. NP Fehm, B Vatankhah, MS Dittmar, Y Tevetoglu, G Retzl, M Horn. „Closing microvascular lesions with fibrin sealant-attached muscle pads“. Microsurgery. 2005; 25(7):570-4.
  16. B Vatankhah, MS Dittmar, N Fehm, P Erban, W Jakob, G Ickenstein, U Bogdahn, M Horn. „Thrombolysis for Stroke in Elderly Patients”. Journal of Thrombosis and Thrombolysis. 2005 Aug; 20 (1), 5-10.
  17. NP Fehm, B Vatankhah, MS Dittmar, G Retzl, G Schuierer, M Horn, F Schlachetzki. „Application of clinical scanners in rats: experimental carotid imaging using magnetic resonance imaging, spiral computed tomography, and color duplex ultrasound”. Journal of Neuroimaging. 2005 Oct; 15(4): 319-325.
  18. MS Dittmar, B Vatankhah, NP Fehm, G Retzl, G Schuierer, U Bogdahn, F Schlachetzki, M Horn. “The role of ECA transection in the development of masticatory lesions in the MCAO filament model.”. Experimental Neurology. 2005 Oct; 195(2): 372-8.
  19. B Vatankhah, A Fürst, F Schlachetzki. Letter to the Editor: “Do Normal D-Dimer Levels Reliably Exclude Cerebral Sinus Thrombosis ?-A solution of problems ?-“ Stroke. 2005 Dec; 36(12):2528-9.
  20. Audebert HJ, Kukla C, Clarmann von Claranau S, Kuhn J, Vatankhah B, Schenkel J, Ickenstein GW, Haberl RL, Horn M; TEMPiS Group. 'Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stgroek Care (TEMPiS) in Bavaria. Stroke 2005; 36: 287-91
  21. B. Vatankhah, M.S. Dittmar, N. P. Fehm, P. Erban, G.W. Ickenstein, W. Jakob, U. Bogdahn, M. Horn (2005) Thrombolysis for stroke in the elderly. J THROMB THROMBOLYSIS 20:25-30
  22. Dittmar MS, Fehm NP, Vatankhah B, Bogdahn U, Schlachetzki F. 'Adverse effects of the MCAO filament model.'  Stroke 2005; 36: 530-2
  23. M.S. Dittmar, N.P. Fehm, B. Vatankhah, U, Bogdahn, F. Schlachetzki, M. Horn (2005) Adverse effects of the intraluminal filament model of middle cerebral artery occlusion (letter). STROKE 36:530-532
  24. W.F. Haupt, J. Rudolf, R. Firsching, H.C. Hansen, T. Henze, M. Horn, W. Müllges (2005) Akutversorgung bewusstloser Patienten in einer interdisziplinären Notaufnahme. INTENSIVMED, 42:457-467
  25. Haas S, Sauerbruch S, Lürding R, Müller G, Hennemann B, Schlachetzki F, Winkler J, Bogdahn U Regeneration beim Akuten Ischämischen Schlaganfall (RAIS): Phase II Studie mit G-CSF bei akutem Mediateilinfarkt In:78. Kongress der Deutschen Gesellschaft für Neurologie 2005 P661
  26. Jürgens T, Koch H, Schmidt-Wilke T, Jakob W, Kaiser B, Bogdahn U, Haas S Späte periphere arterielle Embolie als Komplikation nach invasiver arterieller Blutdruckmessung bei cerebraler Ischämie In:78. Kongress der Deutschen Gesellschaft für Neurologie 2005 P441
  27. Haas S, Jürgens T,Vatankhah B, Schwarz S, Schuierer G, Bogdahn U, Steinbrecher A. Multiple Ischemic Lesions in the vertebro-basilar Region in Temporal Arteritis Nervenarzt 2005 May 18
  28. Audebert HJ, Wimmer ML, Hahn R, Schenkel J, Bogdahn U, Horn M, Haberl RL; on behalf of TEMPIS Group. Can telemedicine contribute to fulfill WHO Helsingborg Declaration of specialized stroke care? Cerebrovasc Dis. 2005;20(5):362-9. Epub 2005 Sep 2
  29. Can telemedicine contribute to fulfill WHO Helsingborg Declaration of specialized stroke care? Cerebrovasc Dis. 2005;20(5):362-9. Epub 2005 Sep 2
  30. Long-term outcome after hemicraniectomy for space occupying right hemispheric MCA infarction. Clin Neurol Neurosurg. 2005 Aug 29;
  31. Dittmar MS, Vatankhah B, Fehm NP, Retzl G, Schuierer G, Bogdahn U, Schlachetzki F, Horn M. 'The role of ECA transection in the development of masticatory lesions in the MCAO filament model. Exp Neurology 2005; 195: 372-8
  32. Erban P, Woertgen C, Luerding R, Bogdahn U, Schlachetzki F, Horn M. 'Impact of age on functional recovery, depression and quality of life after decompressive hemicraniectomy in malignant supratentorial stroke of the right hemisphere.' Surgical Neurology  2005
  33. Fehm NP, Vatankhah B, Dittmar MS, Retzl G, Schuierer G, Horn M, Schlachetzki F. 'Application of clinical scanners in rats: experimental carotid imaging using MRI, spiral CT and color Duplex ultrasound.' J Neuroimaging 2005;  IMPACT 0.974
  34. B Vatankhah, A Fürst, F Schlachetzki. Letter to the Editor: “Do Normal D-Dimer Levels Reliably Exclude Cerebral Sinus Thrombosis ?-A solution of problems ?-“ Stroke. 2005 Dec; 36(12):2528-9.
  35. HJ Audebert, S Clarmann von Clarenau, J Schenkel, A Furst, B Ziemus, C Metz, RL Haberl: „Interhospital emergency transfers of patients after a stroke“ Dtsch Med Wochenschr, 2005 Nov 4;130(44); 2495-500
  36. B Vatankhah, S Schwab, C Kukla, M Hauchwitz, P Erban, B Ziemus, NP Fehm, F Schlachetzki, RL Haberl, U Bogdahn, HJ Audebert, A Fuerst, M Horn. “Tele-Thrombolysis for stroke and its long-term outcome“. Vortrag auf dem 9th Congress of the European Federation of Neurological Societies, September 2005, Athen/Griechenland. European Journal of Neurology 2005, 12 (Suppl. 2): 23.
  37. B Vatankhah, NP Fehm, S Schwab, M Hauchwitz, C Kukla, P Erban, B Ziemus, F Schlachetzki, RL Haberl, U Bogdahn, M Horn, HJ Audebert, A Fuerst.. “Introducing a telemedic stroke network in South-Eastern Bavaria“. Poster auf dem 9th Congress of the European Federation of Neurological Societies, September 2005, Athen/Griechenland. European Journal of Neurology 2005, 12 (Suppl. 2): 40.

 

AG Neuroregeneration

  1. Haas S., Weidner N., and Winkler J. (2005). Adult stem cell therapy in stroke. Curr. Opin. Neurol.18: 59-64.
  2. Winner B, Gross C, Uyanik G, Schulte-Mattler W, Lurding R, Marienhagen J, Bogdahn U, Windpassinger C, Hehr U, Winkler J.: Thin corpus callosum and amyotrophy in spastic paraplegia-Case report and review of literature. Clin Neurol Neurosurg. 2005 Aug 12
  3. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn HG, Winkler J: Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Experimental Neurology 2005 epub.
  4. Couillard-Despres S*, Winner B*, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, and Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis Eur J Neurosci 2005;21:1-14. *contributed equall
  5. Biebl M*, Winner B*, Winkler J: Caspase 3 inhibition decreases cell death without modulation of cell survival. NeuroReport 2005;16(11):1147-50. *contributed equally
  6. Winner B, Gross C, Uyanik G, Schulte-Mattler W, Lürding R, Marienhagen J, Bogdahn U, Windpassinger C, Hehr U, and Winkler J: Thin corpus callosum and amyotrophy in spastic paraplegia. Clinical Neurol Neurosurg 2005 epub.
  7. Haas S, Weidner N, Winkler J. 'Adult stem cell therapy in stroke.' Curr Opin Neurol. 2005; 59-64.
  8. Mueller AM, Pedré X, Kleiter I, Hornberg M, Steinbrecher A*, Giegerich G*: Targeting Fn14-signaling by TWEAK or Fn14 vaccination protects from chronic relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunology 159, 55-65 (2005) *co-senior authors
  9. Winner B, Gross C, Uyanik G, Schulte-Mattler W, Lürding R, Marienhagen J, Bogdahn U, Windpassinger C, Hehr U, Winkler J (2005) Thin corpus callosum and amyotrophy in spastic paraplegia. Clin Neurol Neurosurg Epub 12 Aug 2005
  10. Wohlrab G, Uyanik G, Gross C, Hehr U, Schmitt B, Boltshauser E (2005) Familial West syndrome and dystonia caused by ARX gene mutation. Eur J Peditr 164(5):326-328
  11. Balci B*, Uyanik G*, Dinçer P, Gross C, Willer T, Talim B, Haliloglu G, Kale G, Hehr U, Winkler J, Topaloglu H (2005) An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg-Syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscular Dis 15:271-275, *equal contribution
  12. Meyer S, Struffert T, Uyanik G, Oehl-Jaschkowitz B, Hehr U, Shamdeen MG (2005) Kongenitale Muskeldystrophie: Muscle-Eye-Brain disease. Klinische Pädiatrie 217:68-69
  13. Haliloglu G, Gross C, Senbil N, Talim B, Hehr U, Uyanik G, Winkler J, Topaloglu H (2005) Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features. Acta Myologica 23(3):137-139
  14. Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol. 2005; 18(1):59-64.
  15. Haas S, Bogdahn U, Winkler J. Stammzelleinsatz in der Neurointensivmedizin Kontroversen in der Intensivmedizin (Thieme) 2005 S. 96-101
  16. Hehr U, Hehr A, Uyanik G, Phelan E, Winkler J, Reardon W (2005) A Filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia and severe constipation reminiscent of Cerebro-Fronto-Facial syndrome. J Med Genet Epub 18 Nov 2005
  17. Koch HJ, Uyanik G, Fischer-Barnicol D (2005) Memantine: A therapeutic approach in Alzheimer’s and vascular dementia.Curr Drug Targets CNS Neurol Disord 4:499-506
  18. Koch HJ, Haas S, Jürgens T On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer´s disease Curr Med Chem. 2005;12(24):2915-21)
  19. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J: Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 2005.
  20. Karl C, Couillard-Despres S, Prang P, Munding M, Kilb W, Brigadski T, Plotz S, Mages W, Luhmann H, Winkler J et al: Neuronal precursor-specific activity of a human doublecortin regulatory sequence. J Neurochem 2005, 92(2):264-282.
  21. Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 2005, 21(1):1-14.
  22. Vroemen M., Weidner N., Blesch A. (2005) Loss of gene expression in lentivirus- and retrovirus- transduced neural progenitor cells is correlated to migration and differentiation in the adult spinal cord. Exp. Neurol. 195: 127-193.
  23. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H. G., and Aigner L. (2005). Doublecortin expression levels in adult brain reflect neurogenesis. Eur. J. Neurosci. 21: 1-14.
  24. Karl C., Couillard-Despres S., Prang P., Munding M., Kilb W., Brigadski T., Plötz S., Mages W., Luhmann H., Winkler J., Bogdahn U., Aigner L. (2005). Neuronal precursor specific activity of a human doublecortin regulatory sequence. J. Neurochem, 92:264-282.
  25. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H.-G., Aigner L. (2005). Doublecortin expression levels in adult brain reflect neurogenesis. Eur. J. Neurosci, 21:1-14.
  26. Engelhardt M., Bogdahn U., Aigner L. (2005). Adult retinal pigment epithelium cells express neural progenitor properties and the neuronal precursor protein doublecortin. Brain Res, 1040:98-111.
  27. Winner B., Geyer M., Couillard-Despres S., Aigner R., Bogdahn U., Aigner L., Kuhn G., Winkler J. (2005). Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol. 2005 Oct 21.
  28. Wachs F.-P., Winner B., Couillard-Despres S., Schiller T., Aigner R., Winkler J., Bogdahn U., and Aigner L. Transforming growth factor-b1 is a negative modulator of adult neurogenesis. accepted with minor revision at J. Neuropath. Exp. Neurol.
  29. Karl C., Couillard-Despres S., Prang P., Munding M., Kilb W., Brigadski T., Plötz S., Mages W., Luhmann H., Winkler J., Bogdahn U., Aigner L. (2005). Neuronal precursor specific activity of a human doublecortin regulatory sequence. J. Neurochem, 92:264-282.
  30. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H.-G., Aigner L. (2005). Doublecortin expression levels in adult brain reflect neurogenesis. Eur. J. Neurosci, 21:1-14.
  31. Engelhardt M., Bogdahn U., Aigner L. (2005). Adult retinal pigment epithelium cells express neural progenitor properties and the neuronal precursor protein doublecortin. Brain Res, 1040:98-111.
  32. Winner B., Geyer M., Couillard-Despres S., Aigner R., Bogdahn U., Aigner L., Kuhn G., Winkler J. (2005). Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol. 2005 Oct 21.

 

AG Kopfschmerz / Bildgebung

  1. Busch, V. J., W (2005). "Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes." Cephalalgia (full peer reviewed).
  2. May F., Vroemen M., Matiasek K., Arndt C. Caspers C., Henke J., Brill T., Lehmer A., Erhardt W., Blesch A., Hartung R., Gansbacher B., Weidner N. (2005) Nerve replacement strategies for cavernosal nerves, Eur. Urol., 48: 372-378.
  3. May F., Schoeler S., Vroemen M., Matiasek K., Apprich M., Erhardt W., Hartung, R., Gänsbacher B., and Weidner N. (2005). Nerve repair strategies for restoration of erectile function after radical pelvic surgery. Urologe A 44: 780-784.
  4. Improvement of dialysis headache after treatment with ACE-inhibitors but not angiotensin II receptor blocker: a case report with pathophysiological considerations. Leinisch-Dahlke E, Schmidt-Wilcke T, Kramer BK, May A.
  5. Draganski B, Blersch W, Holmer SR, May A, Bogdahn U, Hölscher T, Schlachetzki F. 'Detection of Cardiac Right-to-Left Shunts by Harmonic Carotid Duplex Sonography.' Ultrasound in Medicine 2005; 24: 1071-6
  6. Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: A neuropsychological and voxel-based morphometric study. J Neurol Sci. 2005 Dec 15;239(1):11-9. Epub 2005 Sep 26.
  7. Gray matter decrease in patients with chronic tension type headache.
    Schmidt-WilckeT, Leinisch E, Straube A, Kampfe N,Draganski B, Diener HC, Bogdahn U, May A.Cephalalgia. 2005 Jan; 25(1):71-4.

 

AG Neuroimmunologie 

  1. Herrlinger U*, Steinbrecher A*, Rieger J, Hau P, Kortmann R-D, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M: Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J. Neurol. 252, 291-299 (2005) *co-first authors
  2. Pöllmann W, Feneberg W, Steinbrecher A, Haupts MR, Henze T: Therapie von Schmerzen bei MS - eine Übersicht mit evidenzbasierten Therapieempfehlungen. Fortschr. Neurol. Psych. 73(5):268-285 (2005)
  3. Reinhold D, Kähne T, Steinbrecher A, Wrenger S, Neubert K, Ansorge S, Brocke S: The role of dipeptidyl peptidase IV (DP IV, CD26) in T cell activation and multiple sclerosis. Signal Transduction (2005) 5, 258-265
  4. Brocke S, Steinbrecher A, Biton A, Ratner M, Preller V , Rotthauwe B, Wrenger S, Reinhold D: Dipeptidyl Peptidase IV Regulates T Cell Function in CNS Inflammation. In: Hooper NM, Lendeckel U (Hrsg.) Proteases in the Brain, Chapter 6, Springer, Berlin, pp 139-150 (2005)
  5. Steinbrecher A: Paroxysmale Symptome. In: Symptomatische Therapie der multiplen Sklerose. Hrsg. T. Henze, Thieme Verlag Stuttgart, pp 112-126 (2005)
  6. “Death receptor-mediated apoptosis in human malignant glioma cells: Modulation by the CD40/CD40L system” Wischhusen, J., Schneider, D., Mittelbronn M., Meyermann, R., Engelmann H., Jung, G., Wiendl, H.,  Weller, M. J Neuroimmunol 2005 May; 162 (1-2): 28-42.

 

AG Elektrophysiologie

  1. Schulte-Mattler W, Kley RA, Rothenfußer-Korber E, Boehm S, Brüning T, Hackemann J, Steinbrecher A, v. Düring M, Voss B, Vorgerd M: Immune-mediated Rippling Muscle Disease - Novel insights through histological studies. Neurology 64, 364-367 (2005)
  2. Schulte-Mattler WJ, Kley RA, Rothenfusser-Korber E, Bohm S, Bruning T, Hackemann J, Steinbrecher A, During MV, Voss B, Vorgerd M. Immune-mediated Rippling Muscle Disease. Neurology 64(2):364-367, 2005.
  3. Schulte-Mattler WJ, Krack P.Response to Gupta VK: Botulinum toxin type A for chronic tension-type headache: Fact versus fiction. Pain. 116:167, 2005.
  4. Schulte-Mattler WJ. Diagnostische Bedeutung von Entladungsraten motorischer Einheiten. Klein Neurophys 36 (3): 110-115, 2005.
  5. W. J. Schulte-Mattler. Pathologische Spontanaktivität im Elektromyogramm. Wie - Wann - Wo: Eine Einführung. Neurophysiol Lab 27(4):221-228, 2005.
  6. Schulte-Mattler WJ, Zierz S: Myotonien und Ionenkanalerkrankungen. In: Berlit, P. (Hrsg.): Klinische Neurologie, 2., aktualisierte u. erw. Aufl., Springer Verlag, Berlin, 2005.
  7. Christian Bischoff, Wilhelm J. Schulte-Mattler, Bastian Conrad. Das EMG-Buch, m. CD-ROM, THIEME, STUTTGART, 2005.

 
    nach oben

Copyright ©  Klinik und Poliklinik für Neurologie der Universität Regensburg